Handok enters licensing agreement for Cetrorelix with AEterma Zentaris
Published: 2008-07-21 06:03:00
Updated: 2008-07-21 06:03:00
Handok Pharm announced on July 14 that it has entered into a licensing agreement with Canada-based AEterma Zentaris Inc. for Cetrorelix (cetrorelix pamoate), a novel investigational luteinizing hormone-releasing hormone (LHRH) antagonist
Under the terms of the agreement, Handok will have an ex...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
